Syros Pharmaceuticals(GB:0LC7)
$0.000.00 (0.00%)
GB:0LC7
Syros Pharmaceuticals financials statements
$0.00
At close:0.00 (0.00%)
Syros Pharmaceuticals (0LC7) Income Statement
1 Followers
Syros Pharmaceuticals Income Statement
Last quarter (Q3 2024), Syros Pharmaceuticals's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q3, Syros Pharmaceuticals's net income was $-6.40M. See Syros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 9.94M | $ 14.88M | $ 23.49M | $ 15.09M | $ 1.98M | |
| $ 7.68M | $ 11.91M | $ 23.49M | $ 15.09M | $ 1.98M | |
| $ 30.77M | $ 38.81M | $ 122.91M | $ 97.39M | $ 79.72M | |
| Depreciation and Amortization | $ 2.25M | $ 2.97M | $ 3.02M | $ 3.04M | $ 2.72M |
| $ -157.19M | $ -87.55M | $ -79.63M | $ -79.21M | $ -72.72M | |
| $ -128.99M | $ -135.87M | $ -99.42M | $ -82.30M | $ -77.74M | |
| $ -35.59M | $ 41.22M | $ 12.86M | $ -1.74M | $ 2.30M | |
| $ -164.57M | $ -94.65M | $ -86.56M | $ -84.04M | $ -75.44M | |
| $ -164.57M | $ -94.65M | $ -86.56M | $ -84.04M | $ -75.44M | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.81 | $ -7.49 | $ -13.84 | $ -18.25 | $ -18.76 |
| Diluted EPS | $ -5.81 | $ -7.49 | $ -13.84 | $ -18.25 | $ -18.76 |
| Weighted Average Shares Outstanding | 28.33M | 12.63M | 6.25M | 4.61M | 4.02M |
| Weighted Average Shares Outstanding (Diluted) | 28.33M | 12.63M | 6.25M | 4.61M | 4.02M |
Currency in USD
